Synthesize Bio logo

Synthesize Bio

synthesize.bio

Synthesize Bio develops generative genomics models that predict how human tissues and cells respond to drugs, diseases, and experimental interventions. Its platform enables drug development teams, clinical development teams, and biopharma partners to simulate clinical trial outcomes, optimize trial design, identify biomarkers, and augment limited datasets with virtual human cohorts. The organization aims to accelerate and de-risk clinical development by providing actionable predictions and insights grounded in large-scale RNA-seq data.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Founded
2023
Type
Corporation Seattle business license
Employees
21
Registered name
Synthesize Bio Seattle business license
Stage
Seed
Founders
Robert Bradley, PhD, Jeff Leek, PhD

Is this your organization? Claim it

If You’re Not Building This Way, How Do You Compete in #tech? #ai #entrepreneur #technology #startup

​@Microsoft EVP of Copilot, Agents, and Platform Charles Lamanna explains how his teams have moved from siloed specialists to general purpose full stack builders who handle design, customer research, code, and deployment themselves. He says the coordination cost of meetings, approvals, and reviews disappears when one person can ship end to end with coding agents. Recorded at the 2026 IA40 Summit in conversation with Madrona’s Matt McIlwain.

Madrona at 30 Years Interview Spotlight: Matt Mcllwain

Madrona Managing Director Matt McIlwain reflects on three decades of partnering with founders and the defining principle of venture: a daring and risky journey. From early wins like Isilon and Smartsheet to today’s era of applied AI, Matt shares why Madrona invests “from day one for the long run” and how community impact has always been central to the firm’s values. This conversation with GeekWire’s John Cook looks back on Madrona’s roots, and forward to the transformational opportunities of the next 30 years.

Matt McIlwain Fireside Chat - Miami Venture Day 2025

Full fireside chat with Matt McIlwain, Managing Director at Madrona ($4B+ AUM) and 3x Forbes Midas List, moderated by Pablo Casilimas, Managing Partner at OneSixOne Ventures. The session was held at the 2nd annual Miami Venture Day on March 26th, 2025 at the Betr office in Miami. OneSixOne Ventures is a VC firm that partners with bold founders on day zero and helps them build legendary companies with offices in Miami, NY and Seattle. https://www.onesixone.ventures/

See all 7 videos about Synthesize Bio.

People

  • Jeff Leek
    Jeff Leek Co-founder, Co-CEO
  • Alice M. Walsh Executive, COO

Online